New Zealand markets closed

IDEXX Laboratories, Inc. (IDXX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
465.82-0.92 (-0.20%)
At close: 04:00PM EST
465.68 -0.14 (-0.03%)
Pre-market: 09:25AM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 38.69B
Enterprise value 39.50B
Trailing P/E 47.48
Forward P/E 46.30
PEG ratio (5-yr expected) 4.60
Price/sales (ttm)10.90
Price/book (mrq)29.82
Enterprise value/revenue 11.01
Enterprise value/EBITDA 33.07

Trading information

Stock price history

Beta (5Y monthly) 1.21
52-week change 37.01%
S&P500 52-week change 312.18%
52-week high 3564.74
52-week low 3372.50
50-day moving average 3436.92
200-day moving average 3476.50

Share statistics

Avg vol (3-month) 3494.6k
Avg vol (10-day) 3432.51k
Shares outstanding 583.05M
Implied shares outstanding 683.05M
Float 882.19M
% held by insiders 10.92%
% held by institutions 191.32%
Shares short (14 Nov 2023) 42.77M
Short ratio (14 Nov 2023) 44.99
Short % of float (14 Nov 2023) 43.76%
Short % of shares outstanding (14 Nov 2023) 43.34%
Shares short (prior month 12 Oct 2023) 42.75M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 315 Jun 2015

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 Sept 2023


Profit margin 22.93%
Operating margin (ttm)30.07%

Management effectiveness

Return on assets (ttm)23.54%
Return on equity (ttm)92.79%

Income statement

Revenue (ttm)3.59B
Revenue per share (ttm)43.22
Quarterly revenue growth (yoy)8.80%
Gross profit (ttm)2B
Net income avi to common (ttm)822.73M
Diluted EPS (ttm)9.83
Quarterly earnings growth (yoy)17.30%

Balance sheet

Total cash (mrq)331.7M
Total cash per share (mrq)3.99
Total debt (mrq)1.14B
Total debt/equity (mrq)87.91%
Current ratio (mrq)1.43
Book value per share (mrq)15.62

Cash flow statement

Operating cash flow (ttm)830.09M
Levered free cash flow (ttm)586.36M